Trial Profile
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2016
Price :
$35
*
At a glance
- Drugs Velafermin (Primary)
- Indications Stomatitis
- Focus Therapeutic Use
- Sponsors CuraGen Corporation
- 17 Mar 2016 New trial record